Literature DB >> 280712

Effect of intestinal microflora on 2,2'-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats.

B S Reddy, K Watanabe.   

Abstract

The effect of intestinal microflora on colon and breast carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB) was studied with the use of germfree and conventional F344 rats of both sexes. At 7 weeks of age, all animals except controls were given 20 weekly sc injections of DMAB in corn oil (100 mg/kg body wt/wk). Male animals were autopsied 15 weeks after the last injection, whereas female animals were autopsied 10 weeks after the last injection. Tumors were induced in the colons, duodena, breasts, ear ducts, salivary glands, and skin of conventional rats, and in the colons, breasts, ear ducts, salivary glands, and skin of germfree rats. No consistent difference was found in the incidence of tumors in the ear ducts, salivary glands, and skin between the germfree and conventional rats. None of the germfree rats showed duodenal tumors, whereas 13% of the female and 53% of the male conventional rats developed duodenal tumors. The incidence of intestinal tumors was lower in the germfree rats than in conventional animals. The mammary tumor incidence was lower in germfree female rats than in the conventional female rats than in the conventional females. DMAB induced fewer intestinal and breast tumors in germfree rats than in conventional rats.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280712     DOI: 10.1093/jnci/61.5.1269

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

Review 1.  Role of the microbiome in non-gastrointestinal cancers.

Authors:  Meirav Pevsner-Fischer; Timur Tuganbaev; Mariska Meijer; Sheng-Hong Zhang; Zhi-Rong Zeng; Min-Hu Chen; Eran Elinav
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 2.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

Review 3.  The Yin and Yang of Toll-like receptors in cancer.

Authors:  J-P Pradere; D H Dapito; R F Schwabe
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

Review 4.  Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.

Authors:  Jeremy Goc; Matthew R Hepworth; Gregory F Sonnenberg
Journal:  Int Immunol       Date:  2015-10-07       Impact factor: 4.823

Review 5.  The microbiome and cancer.

Authors:  Robert F Schwabe; Christian Jobin
Journal:  Nat Rev Cancer       Date:  2013-10-17       Impact factor: 60.716

6.  In vivo metabolism of 3,2'-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat.

Authors:  M Nussbaum; E S Fiala; B Kulkarni; K El-Bayoumy; J H Weisburger
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

7.  Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.

Authors:  Steven N Steinway; Matthew B Biggs; Thomas P Loughran; Jason A Papin; Reka Albert
Journal:  PLoS Comput Biol       Date:  2015-06-23       Impact factor: 4.475

8.  The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease.

Authors:  Tina J Hieken; Jun Chen; Tanya L Hoskin; Marina Walther-Antonio; Stephen Johnson; Sheri Ramaker; Jian Xiao; Derek C Radisky; Keith L Knutson; Krishna R Kalari; Janet Z Yao; Larry M Baddour; Nicholas Chia; Amy C Degnim
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

Review 9.  The Microbiome and Its Implications in Cancer Immunotherapy.

Authors:  Hani Choudhry
Journal:  Molecules       Date:  2021-01-03       Impact factor: 4.411

Review 10.  New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries.

Authors:  Tejeshwar Jain; Prateek Sharma; Abhi C Are; Selwyn M Vickers; Vikas Dudeja
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.